Compare $BIXT vs $KAPA | Chartloom

Compare

$BIXT vs $KAPA

Bioxytran Inc · Kairos Pharma Ltd

BIXT

Bioxytran Inc

KAPA

Kairos Pharma Ltd

Compare $BIXT vs $KAPA

Comparing Bioxytran Inc and Kairos Pharma Ltd

BIXTBioxytran Inc

KAPAKairos Pharma Ltd

BIXTBioxytran Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-68.2%

52W performance

-67.7%

FCF yield

-34.2%

KAPAKairos Pharma Ltd

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.1%

52W performance

-91.2%

FCF yield

-22.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BIXT

KAPA

Detailed metrics comparison

BIXT

Bioxytran Inc

KAPA

Kairos Pharma Ltd

Market Cap

BIXT$3M

KAPA$17M

Enterprise Value

BIXT$4M

KAPA$15M

Price

BIXT$0.02

KAPA$0.81

P/E Ratio

BIXTN/A

KAPAN/A

P/S Ratio

BIXT18.76x

KAPA0.00x

EV/Sales

BIXT19.26x

KAPA0.00x

EV/EBITDA

BIXT121.99x

KAPA0.00x

P/B Ratio

BIXT4.86x

KAPA1.26x

P/FCF Ratio

BIXTN/A

KAPAN/A

EV/FCF

BIXT-4.08x

KAPA-3.71x

PEG Ratio

BIXTN/A

KAPAN/A

Forward P/E (NTM)

BIXTN/A

KAPAN/A

Forward P/S (NTM)

BIXTN/A

KAPAN/A

Revenue (TTM)

BIXT$0

KAPA$0

Revenue Growth (YoY)

BIXTN/A

KAPAN/A

Forward Rev Growth

BIXT0.0%

KAPA0.0%

Gross Margin (TTM)

BIXT47.4%

KAPA0.0%

Operating Margin (TTM)

BIXT0.0%

KAPA0.0%

EBITDA Margin (TTM)

BIXT0.0%

KAPA0.0%

Net Margin (TTM)

BIXT0.0%

KAPA0.0%

FCF Margin (TTM)

BIXTN/A

KAPAN/A

Net Income (TTM)

BIXT$-3M

KAPA$-6M

FCF (TTM)

BIXT$-893K

KAPA$-4M

EPS (TTM)

BIXT-$0.03

KAPA-$0.27

ROE (TTM)

BIXT-755.0%

KAPA-9877.0%

ROA (TTM)

BIXT-79248.0%

KAPA-9361.0%

ROIC (TTM)

BIXT-612.0%

KAPA-9877.0%

Cash

BIXT$177K

KAPA$3M

Debt

BIXT$1M

KAPA$0

Net Cash/Debt

BIXT$-1M

KAPA$3M

Current Ratio (TTM)

BIXT0.03x

KAPA11.98x

Quick Ratio (TTM)

BIXT0.03x

KAPA11.46x

Debt/Equity (TTM)

BIXT0.20x

KAPA0.00x

Debt/Assets (TTM)

BIXT0.0%

KAPA0.0%

Interest Coverage (TTM)

BIXTN/A

KAPAN/A

Net Debt/EBITDA (TTM)

BIXT0.00x

KAPA0.00x

Beta

BIXT2.80

KAPA3.30

52W Performance

BIXT-67.7%

KAPA-91.2%

YTD Performance

BIXT-68.2%

KAPA-84.1%

% from 52W High

BIXT-75.9%

KAPA-91.6%

% from 52W Low

BIXT14.5%

KAPA3.5%

Asset Turnover (TTM)

BIXT0.50x

KAPA0.00x

FCF Yield (TTM)

BIXT-34.2%

KAPA-22.9%

Earnings Yield (TTM)

BIXT-133.6%

KAPA-33.5%

Dividend Yield (TTM)

BIXTN/A

KAPAN/A

Rule of 40

BIXT0.0

KAPA0.0

EV/GP/RG

BIXTN/A

KAPAN/A

Ticker research

View BIXT research View KAPA research

Metric	BIXT Bioxytran Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$3M	$17M
Enterprise Value	$4M	$15M
Price	$0.02	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	18.76x	0.00x
EV/Sales	19.26x	0.00x
EV/EBITDA	121.99x	0.00x
P/B Ratio	4.86x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.08x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	47.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-6M
FCF (TTM)	$-893K	$-4M
EPS (TTM)	-$0.03	-$0.27
ROE (TTM)	-755.0%	-9877.0%
ROA (TTM)	-79248.0%	-9361.0%
ROIC (TTM)	-612.0%	-9877.0%
Financial Health
Cash	$177K	$3M
Debt	$1M	$0
Net Cash/Debt	$-1M	$3M
Current Ratio (TTM)	0.03x	11.98x
Quick Ratio (TTM)	0.03x	11.46x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.80	3.30
52W Performance	-67.7%	-91.2%
YTD Performance	-68.2%	-84.1%
% from 52W High	-75.9%	-91.6%
% from 52W Low	14.5%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.00x
FCF Yield (TTM)	-34.2%	-22.9%
Earnings Yield (TTM)	-133.6%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIXT research	View KAPA research

Valuation

P/S Ratio

KAPA

0.00x

BIXT

18.76x

EV/FCF

BIXT

-4.08x

KAPA

-3.71x

Growth & revenue

Forward Revenue Growth

BIXT

0.0%

KAPA

0.0%

Profitability & performance

Gross Margin

BIXT

47.4%

KAPA

0.0%

ROE

BIXT

-755.0%

KAPA

-9877.0%

FCF Yield %

KAPA

-22.9%

BIXT

-34.2%

52-Week Performance

BIXT

-67.7%

KAPA

-91.2%

Detailed metrics comparison

BIXT

Bioxytran Inc

KAPA

Kairos Pharma Ltd

Market Cap

BIXT$3M

KAPA$17M

Enterprise Value

BIXT$4M

KAPA$15M

Price

BIXT$0.02

KAPA$0.81

P/E Ratio

BIXTN/A

KAPAN/A

P/S Ratio

BIXT18.76x

KAPA0.00x

EV/Sales

BIXT19.26x

KAPA0.00x

EV/EBITDA

BIXT121.99x

KAPA0.00x

P/B Ratio

BIXT4.86x

KAPA1.26x

P/FCF Ratio

BIXTN/A

KAPAN/A

EV/FCF

BIXT-4.08x

KAPA-3.71x

PEG Ratio

BIXTN/A

KAPAN/A

Forward P/E (NTM)

BIXTN/A

KAPAN/A

Forward P/S (NTM)

BIXTN/A

KAPAN/A

Revenue (TTM)

BIXT$0

KAPA$0

Revenue Growth (YoY)

BIXTN/A

KAPAN/A

Forward Rev Growth

BIXT0.0%

KAPA0.0%

Gross Margin (TTM)

BIXT47.4%

KAPA0.0%

Operating Margin (TTM)

BIXT0.0%

KAPA0.0%

EBITDA Margin (TTM)

BIXT0.0%

KAPA0.0%

Net Margin (TTM)

BIXT0.0%

KAPA0.0%

FCF Margin (TTM)

BIXTN/A

KAPAN/A

Net Income (TTM)

BIXT$-3M

KAPA$-6M

FCF (TTM)

BIXT$-893K

KAPA$-4M

EPS (TTM)

BIXT-$0.03

KAPA-$0.27

ROE (TTM)

BIXT-755.0%

KAPA-9877.0%

ROA (TTM)

BIXT-79248.0%

KAPA-9361.0%

ROIC (TTM)

BIXT-612.0%

KAPA-9877.0%

Cash

BIXT$177K

KAPA$3M

Debt

BIXT$1M

KAPA$0

Net Cash/Debt

BIXT$-1M

KAPA$3M

Current Ratio (TTM)

BIXT0.03x

KAPA11.98x

Quick Ratio (TTM)

BIXT0.03x

KAPA11.46x

Debt/Equity (TTM)

BIXT0.20x

KAPA0.00x

Debt/Assets (TTM)

BIXT0.0%

KAPA0.0%

Interest Coverage (TTM)

BIXTN/A

KAPAN/A

Net Debt/EBITDA (TTM)

BIXT0.00x

KAPA0.00x

Beta

BIXT2.80

KAPA3.30

52W Performance

BIXT-67.7%

KAPA-91.2%

YTD Performance

BIXT-68.2%

KAPA-84.1%

% from 52W High

BIXT-75.9%

KAPA-91.6%

% from 52W Low

BIXT14.5%

KAPA3.5%

Asset Turnover (TTM)

BIXT0.50x

KAPA0.00x

FCF Yield (TTM)

BIXT-34.2%

KAPA-22.9%

Earnings Yield (TTM)

BIXT-133.6%

KAPA-33.5%

Dividend Yield (TTM)

BIXTN/A

KAPAN/A

Rule of 40

BIXT0.0

KAPA0.0

EV/GP/RG

BIXTN/A

KAPAN/A

Ticker research

View BIXT research View KAPA research

Metric	BIXT Bioxytran Inc	KAPA Kairos Pharma Ltd
Market & Valuation
Market Cap	$3M	$17M
Enterprise Value	$4M	$15M
Price	$0.02	$0.81
P/E Ratio	N/A	N/A
P/S Ratio	18.76x	0.00x
EV/Sales	19.26x	0.00x
EV/EBITDA	121.99x	0.00x
P/B Ratio	4.86x	1.26x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.08x	-3.71x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	47.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-3M	$-6M
FCF (TTM)	$-893K	$-4M
EPS (TTM)	-$0.03	-$0.27
ROE (TTM)	-755.0%	-9877.0%
ROA (TTM)	-79248.0%	-9361.0%
ROIC (TTM)	-612.0%	-9877.0%
Financial Health
Cash	$177K	$3M
Debt	$1M	$0
Net Cash/Debt	$-1M	$3M
Current Ratio (TTM)	0.03x	11.98x
Quick Ratio (TTM)	0.03x	11.46x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.80	3.30
52W Performance	-67.7%	-91.2%
YTD Performance	-68.2%	-84.1%
% from 52W High	-75.9%	-91.6%
% from 52W Low	14.5%	3.5%
Efficiency & Yields
Asset Turnover (TTM)	0.50x	0.00x
FCF Yield (TTM)	-34.2%	-22.9%
Earnings Yield (TTM)	-133.6%	-33.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BIXT research	View KAPA research